Johnson & Johnson Shares Slide 4.65% in Four Days Amidst 66th Ranked Trading Volume

Johnson & Johnson (JNJ) shares fell 0.62% on June 20, 2025, marking the fourth consecutive day of decline, with a total decrease of 4.65% over the past four days. The company's trading volume reached 11.06 billion, ranking 66th in the day's market activity.

Johnson & Johnson MedTech, a global leader in orthopedic technologies, has launched the VOLT™ Distal Radius (Wrist) and VOLT™ Proximal Humerus 3.5 Plating Systems. These innovations are designed to address common fractures, particularly in the elderly population. The VOLT™ Wrist Treatment System includes the VOLT Two-Column Distal Radius Rim Plate, which features a new plate shape that allows it to sit more distally to the target distal fragments, reducing the risk of soft tissue irritation. The VOLT™ Proximal Humerus 3.5 Plating System offers variable angle locking technology and more plate length options, providing surgeons with greater flexibility in treating upper arm fractures.

These new systems are part of Johnson & Johnson's ongoing commitment to improving outcomes for patients with orthopedic injuries. The company has a long-standing legacy in trauma care and continues to innovate with solutions that address the complexities of upper extremity fractures. The VOLT™ Distal Radius and Proximal Humerus 3.5 Plating Systems are now commercially available in the U.S., with additional anatomic plating solutions expected to be introduced in the coming years.